Intercept Pharmaceuticals, Inc. logo
Intercept Pharmaceuticals Announces 2014 Financial Results
March 02, 2015 06:00 ET | Intercept Pharmaceuticals, Inc.
NEW YORK, March 2, 2015 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of...
LOGO JPG.jpg
Cempra Reports Fourth Quarter and Full Year 2014 Financial Results and Provides Corporate Update
February 25, 2015 16:00 ET | Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., Feb. 25, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
Raptor Pharmaceutica
Raptor Pharmaceutical to Attend Upcoming Investor Conferences
February 18, 2015 08:00 ET | Raptor Pharmaceutical Inc
NOVATO, Calif., Feb. 18, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that Michael Smith, Chief Financial Officer will participate in the following investor...
Raptor Pharmaceutica
Raptor Pharmaceutical to Hold Fourth Quarter and Full Year 2014 Financial Results Conference Call and Webcast on Thursday, February 26, 2015 at 4:30 p.m. ET
February 17, 2015 08:00 ET | Raptor Pharmaceutical Inc
NOVATO, Calif., Feb. 17, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that the company will release fourth quarter and full year 2014 financial results on...
Raptor Pharmaceutica
Raptor Pharmaceutical to Present at the 2015 Leerink Global Healthcare Conference
January 30, 2015 13:30 ET | Raptor Pharmaceutical Inc
NOVATO, Calif., Jan. 30, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that it will present at the following conference: Julie Anne Smith, President and Chief...
Raptor Pharmaceutica
Raptor Pharmaceutical Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
January 20, 2015 08:00 ET | Raptor Pharmaceutical Inc
NOVATO, Calif., Jan. 20, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that on January 15, 2015, a majority of the independent members of the Company's Board of...
Raptor Pharmaceutica
Raptor Pharmaceutical Appoints Gregg Lapointe and Georges Gemayel to Board of Directors
December 18, 2014 07:30 ET | Raptor Pharmaceutical Inc
NOVATO, Calif., Dec. 18, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced the appointment of Gregg Lapointe and Georges Gemayel, Ph.D. to its Board of Directors,...
Raptor Pharmaceutica
Raptor Pharmaceutical Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
December 01, 2014 09:00 ET | Raptor Pharmaceutical Inc
NOVATO, Calif., Dec. 1, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that on November 25, 2014, as a key requirement of the Company's strategy of strengthening...
Raptor Pharmaceutica
Raptor Pharmaceutical to Present at the 26th Annual Piper Jaffray Healthcare Conference
November 18, 2014 16:05 ET | Raptor Pharmaceutical Inc
NOVATO, Calif., Nov. 18, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that the company will participate in the following conference: Julie Anne Smith,...
Raptor Pharmaceutica
Raptor Pharmaceutical Reports Third Quarter 2014 Financial Results and Provides Corporate Update
November 06, 2014 16:05 ET | Raptor Pharmaceutical Inc
Global Net Product Sales for PROCYSBI® of $23.8 Million for Third Quarter 2014 PROCYSBI Revenue of $52.2 Million Reached Through September 2014 PROCYSBI Revenue Guidance of $65-$70 Million...